MedPath

Effect of medium-term, moderate hypoxia on sleep patterns, pulmonary blood flow, hemorheology, and exercise capacity in patients with Fontan circulation.

Recruiting
Conditions
Fontan circulation
Registration Number
DRKS00025989
Lead Sponsor
Abteilung für Kinderkardiologie des Universitätsklinikums Bonn
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Hemodynamically stable Fontan patients (10 w; 10 m).
- Age 16 to 30 years
- Peripheral saustoff saturation = 90%.
- Physical and mental ability to complete spiroergometry on a bicycle ergometer
- Signed informed consent (If underage, also signed informed consent from both parents).

Exclusion Criteria

- Failing Fontan (protein-losing enteropathy, ascites, bronchitis plastica, NYHA stage III or IV).
- Fenestration in the Fontan tunnel
- Peripheral oxygen saturation < 90 % in normoxia
- Stent in pulmonary artery, Glenn anastomosis and/or proximal tunnel of Fontan
- Claustrophobia
- smoker
- Obesity (BMI = 30)
- Cardiac pacemaker
- Acute infections
- Medication with sildenafil or bosentan
- Medication with hypnotics
- Known sleep disorders
- Known depression, previous psychiatric illnesses

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The main objectives of the sleep study are:<br><br>1. to determine the minimum nocturnal value of peripheral oxygen saturation and the proportion of sleep time spent during which oxygen saturation falls below 85%.<br>2. polysomnographic recording of sleep in Fontan patients under moderate normobaric hypoxia exposure. In particular, the sleep efficiency and the proportion of different sleep stages and waking phases will be determined.<br>3. to collect first normative data for Fontan patients, which will then be compared with data from preliminary studies of healthy control subjects under hypoxia.<br><br><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath